These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34085298)

  • 1. BAP1-inactivated melanocytic tumors show prominent centrosome amplification and associated loss of primary cilia.
    Ye J; Sheahon KM; LeBoit PE; McCalmont TH; Lang UE
    J Cutan Pathol; 2021 Nov; 48(11):1353-1360. PubMed ID: 34085298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and dermoscopic features of cutaneous BAP1-inactivated melanocytic tumors: Results of a multicenter case-control study by the International Dermoscopy Society.
    Yélamos O; Navarrete-Dechent C; Marchetti MA; Rogers T; Apalla Z; Bahadoran P; Blázquez-Sánchez N; Busam K; Carrera C; Dusza SW; de la Fouchardière A; Ferrara G; Gerami P; Kittler H; Lallas A; Malvehy J; Millán-Cayetano JF; Nelson KC; Quan VL; Puig S; Stevens H; Thomas L; Marghoob AA
    J Am Acad Dermatol; 2019 Jun; 80(6):1585-1593. PubMed ID: 30244062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histomorphologic spectrum of germline-related and sporadic BAP1-inactivated melanocytic tumors.
    Garfield EM; Walton KE; Quan VL; VandenBoom T; Zhang B; Kong BY; Isales MC; Panah E; Kim G; Gerami P
    J Am Acad Dermatol; 2018 Sep; 79(3):525-534. PubMed ID: 29753057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline BRCA1-associated protein 1 mutation presenting as BAP1 inactivated melanocytic nevi in a child of a father with fatal paraganglioma.
    Watchorn RE; Calonje E; Taibjee SM
    Pediatr Dermatol; 2018 Sep; 35(5):e316-e318. PubMed ID: 29974497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel insights into the BAP1-inactivated melanocytic tumor.
    Donati M; Martinek P; Steiner P; Grossmann P; Vanecek T; Kastnerova L; Kolm I; Baneckova M; Donati P; Kletskaya I; Kalmykova A; Feit J; Blasch P; Szilagyi D; Baldi A; Persichetti P; Crescenzi A; Michal M; Kazakov DV
    Mod Pathol; 2022 May; 35(5):664-675. PubMed ID: 34857909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAF1 Gene Fusions as a Possible Driver Mechanism in Rare BAP1-Inactivated Melanocytic Tumors: A Report of 2 Cases.
    Donati M; Martinek P; Kastnerova L; Persichetti P; Michal M; Kazakov DV
    Am J Dermatopathol; 2020 Dec; 42(12):961-966. PubMed ID: 32769548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAP1 tumor predisposition syndrome case report: pathological and clinical aspects of BAP1-inactivated melanocytic tumors (BIMTs), including dermoscopy and confocal microscopy.
    Soares de Sá BC; de Macedo MP; Torrezan GT; Braga JCT; Fidalgo F; Moredo LF; Lellis R; Duprat JP; Carraro DM
    BMC Cancer; 2019 Nov; 19(1):1077. PubMed ID: 31706282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The morphologic spectrum of germline-mutated BAP1-inactivated melanocytic tumors includes lesions with conventional nevic melanocytes: A case report and review of literature.
    Wysozan TR; Khelifa S; Turchan K; Alomari AK
    J Cutan Pathol; 2019 Nov; 46(11):852-857. PubMed ID: 31206729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCA1-associated protein (BAP1)-inactivated melanocytic tumors.
    Zhang AJ; Rush PS; Tsao H; Duncan LM
    J Cutan Pathol; 2019 Dec; 46(12):965-972. PubMed ID: 31233225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.
    Piris A; Mihm MC; Hoang MP
    Hum Pathol; 2015 Feb; 46(2):239-45. PubMed ID: 25479927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BAP1 deficient malignant melanoma arising from the intradermal component of a congenital melanocytic naevus.
    Ardakani NM; Palmer DL; Wood BA
    Pathology; 2015 Dec; 47(7):707-10. PubMed ID: 26517632
    [No Abstract]   [Full Text] [Related]  

  • 12. Germline mutations in BAP1 predispose to melanocytic tumors.
    Wiesner T; Obenauf AC; Murali R; Fried I; Griewank KG; Ulz P; Windpassinger C; Wackernagel W; Loy S; Wolf I; Viale A; Lash AE; Pirun M; Socci ND; Rütten A; Palmedo G; Abramson D; Offit K; Ott A; Becker JC; Cerroni L; Kutzner H; Bastian BC; Speicher MR
    Nat Genet; 2011 Aug; 43(10):1018-21. PubMed ID: 21874003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential.
    van Poppelen NM; Vaarwater J; Mudhar HS; Sisley K; Rennie IG; Rundle P; Brands T; van den Bosch QCC; Mensink HW; de Klein A; Kiliç E; Verdijk RM
    Ophthalmology; 2018 Jun; 125(6):904-912. PubMed ID: 29371009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambiguous melanocytic tumors with loss of 3p21.
    Yeh I; Mully TW; Wiesner T; Vemula SS; Mirza SA; Sparatta AJ; McCalmont TH; Bastian BC; LeBoit PE
    Am J Surg Pathol; 2014 Aug; 38(8):1088-95. PubMed ID: 24705312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difficult to Diagnose Cutaneous Melanoma in a Patient with BAP1 Tumor Predisposition Syndrome.
    Silva-Clavería F; Álvarez-Muñoz A; Ferrándiz L; Fernández-Orland A; Conde-Martin AF; Moreno-Ramírez D; Ríos-Martín JJ
    Int J Surg Pathol; 2023 Oct; 31(7):1398-1402. PubMed ID: 36803128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of molecularly confirmed BAP1 inactivated melanocytic tumor with retention of immunohistochemical expression: A confounding factor.
    Linos K; Atkinson AE; Yan S; Tsongalis GJ; Lefferts JA
    J Cutan Pathol; 2020 May; 47(5):485-489. PubMed ID: 31891422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAP1-inactivated melanocytic tumour with borderline histopathological features (BAP1-inactivated melanocytoma): A case report and a reappraisal.
    Ferrara G; Mariani MP; Auriemma M
    Australas J Dermatol; 2021 Feb; 62(1):e88-e91. PubMed ID: 33107024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of primary cilia correlates with cytologic severity in dysplastic melanocytic nevi.
    Lang UE; Cheung C; Vladar EK; Swetter SM; Kim J
    J Cutan Pathol; 2016 Feb; 43(2):113-9. PubMed ID: 26272818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, dermoscopic, histological and molecular analysis of BAP1-inactivated melanocytic naevus/tumour in two familial cases of BAP1 syndrome.
    Moawad S; Reigneau M; de la Fouchardière A; Soufir N; Schmutz JL; Granel-Brocard F; Phan A; Bursztejn AC
    Br J Dermatol; 2018 Oct; 179(4):973-975. PubMed ID: 29754391
    [No Abstract]   [Full Text] [Related]  

  • 20. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.
    Marušić Z; Buljan M; Busam KJ
    J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.